MyFinsight
Home
Compare
About
Recent SEC Filings
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
LABT Cash Flow Sankey Diagram
Sankey diagram visualizing LABT cash flow for the period
Net proceeds from
issuance of series c...
$6,802,095
Proceeds from notes
payable - related...
$43,158
Proceeds from notes
payable other
$30,000
Net cash provided by
financing activities
$6,677,095
Canceled cashflow
$198,158
Net increase in cash
and cash...
$2,573,065
Canceled cashflow
$4,104,030
Repayment of notes payable
- related parties
$168,158
Repayment of notes payable
- other
$30,000
Issuance of common stock
for professional...
$2,434,080
Stock-based compensation
$61,245
Amortization of right-of-use
asset
$29,538
Accrued interest
related parties
$8,219
Depreciation
$1,158
Net cash used in
operating activities
-$2,104,030
Net cash used in
investing activities
-$2,000,000
Canceled cashflow
$2,534,240
Net loss
-$3,772,008
Purchases of investments
$2,000,000
Accounts payable
-$381,887
Accrued expenses and
other current...
-$233,358
Prepaid expenses and
other assets
$221,297
Operating lease liability
-$29,720
Back
Back
Lakewood-Amedex Biotherapeutics Inc. (LABT)
Lakewood-Amedex Biotherapeutics Inc. (LABT)
Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com